Bimatoprost is under clinical development by Laboratoires Thea and currently in Phase III for Ocular Hypertension. According to GlobalData, Phase III drugs for Ocular Hypertension have a 75% phase ...

Radcliffe demonstrates how to find the right angle of implantation for Durysta (bimatoprost intracameral implant, Allergan) in order to avoid endothelial cell loss. “I inject a lot of ...

Netflix claims Broadcom's subsidiary VMware is in violation of five patents It claims VMware knew it was violating patents for more than a decade Netflix is now demanding VMware pays for damages ...

Dec 23 (Reuters) - Abbott Laboratories (ABT.N), opens new tab and DexCom (DXCM.O), opens new tab said on Monday they have reached an agreement to settle all patent disputes between them related to ...

What just happened? Netflix is suing Broadcom, alleging infringement of multiple patents related to virtual machine operations. The video streaming giant alleges that VMware products like vSphere ...

Sauvegarder Investment Management (SIM) is seeking a Senior Patent Analyst. As a Senior Patent Analyst at SIM, you’ll be part of a high-performing, results-driven team. This is not just a job ...

Video streaming giant Netflix Inc. is suing Broadcom Inc. over virtual machine patents owned by the company’s subsidiary VMware Inc. According to the lawsuit filed with a California federal ...

Dec 20 (Reuters) - Teva Pharmaceuticals (TEVA.TA), opens new tab failed to convince a U.S. appeals court on Friday to reverse a decision that would remove patents related to its ProAir HFA inhaler ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) There is still no ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...